ICICI Securities Ltd | Retail Equity Research Amid de-stocking ahead of GST implementation and a tepid demand environment, total revenues (including auxiliary income) declined only 1.3% YoY to | 1045.9 crore (I-direct estimate: | 977.0 crore). Though revenues were impacted by disruption in CSD & wholesale channels, GSK's initiatives like rolling out of various schemes, extended credit period and compensation for tax difference helped restricted any fall in volumes. Volumes remained flat for the quarter...